MWNA
ELV icon

Marshall Wace North America’s Elevance Health ELV Stock Holding History

Marshall Wace North America’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4.85M Sell
13,003
-421,333
-97% -$160M 0.02% 523
2021
Q2 		$166M Sell
434,336
-341,135
-44% -$130M 0.69% 21
2021
Q1 		$278M Sell
775,471
-72,377
-9% -$23.3M 1.15% 9
2020
Q4 		$272M Buy
847,848
+613,872
+262% +$188M 1.23% 9
2020
Q3 		$62.8M Buy
233,976
+83,708
+56% +$22.5M 0.4% 55
2020
Q2 		$39.5M Buy
150,268
+141,142
+1,547% +$37.7M 0.26% 98
2020
Q1 		$2.07M Buy
9,126
+5,196
+132% +$1.42M 0.02% 473
2019
Q4 		$1.19M Buy
3,930
+2,462
+168% +$678K 0.01% 687
2019
Q3 		$353K Sell
1,468
-16,304
-92% -$4.47M ﹤0.01% 865
2019
Q2 		$5.01M Sell
17,772
-353,403
-95% -$96.5M 0.03% 361
2019
Q1 		$107M Buy
371,175
+347,887
+1,494% +$101M 0.75% 29
2018
Q4 		$6.12M Sell
23,288
-1,474
-6% -$405K 0.06% 221
2018
Q3 		$6.79M Buy
24,762
+15,253
+160% +$3.96M 0.05% 264
2018
Q2 		$2.26M Sell
9,509
-288
-3% -$66.7K 0.01% 736
2018
Q1 		$2.15M Buy
9,797
+2,855
+41% +$671K 0.01% 797
2017
Q4 		$1.56M Sell
6,942
-35,475
-84% -$7.56M 0.01% 900
2017
Q3 		$8.06M Buy
42,417
+37,761
+811% +$7.19M 0.05% 424
2017
Q2 		$875K Buy
+4,656
New +$837K 0.01% 967

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Marshall Wace North America's ELV Position: Q3 2021 in Review

Marshall Wace North America reduced its Elevance Health (ELV) stake by 97% in Q3 2021, selling an estimated $160M and leaving 13,003 shares worth $4.85M. The position accounts for 0.02% of the portfolio, ranked #523.

Marshall Wace North America first reported a position in ELV in Q2 2017 and has held it in 18 quarters since. The position peaked at $278M in Q1 2021. 1,217 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Marshall Wace North America held 13,003 shares of Elevance Health worth $4.85M as of Q3 2021.
  • Marshall Wace North America sold 421,333 Elevance Health shares in Q3 2021, an estimated $160M.
  • Elevance Health made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #523 holding.
  • Marshall Wace North America first reported a position in Elevance Health in Q2 2017 and has held it in 18 quarters since.
  • Marshall Wace North America's Elevance Health position peaked at $278M in Q1 2021.
  • 1,217 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.